Skip to content

Safety and utility of the shielding devise for infection control during the upper gastrointestinal endoscopic procedures.

Safety and utility of the shielding devise for infection control during the upper gastrointestinal endoscopic procedures. - Safety and utility of the shielding devise for infection control during the upper gastrointestinal endoscopic procedures.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045902
Enrollment
10
Registered
2021-10-29
Start date
2021-11-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal tract disease

Interventions

Intervention group: The mask-like shielding device is attached to the patient during the endoscopy. In addition, the drape is attached to the endoscope, and the doctor operates the endoscope through t

Sponsors

Toranomon Hospital, Tokyo, Japan
Lead Sponsor
OLYMPUS MEDICAL SYSTEMS CORPORATION
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients planning to undergo biopsy, chromoendoscopy, or procedure with a Miniature probe during upper gastrointestinal endoscopy

Exclusion criteria

Exclusion criteria: Patients with severe pulmonary dysfunction requiring oxygen administration. Patients who did not agree to participate in this study.

Design outcomes

Primary

MeasureTime frame
Discoloration area of water-sensitive paper due to the doctor's gloves after the endoscopy

Secondary

MeasureTime frame
Discoloration area of water-sensitive recording paper placed in front of the patient, Number of particles measured with a particle counter during endoscopy, Discoloration area of water-sensitive paper due to the endoscopy technician's gloves after the endoscopy, Oxygen saturation during the endoscopy, Blood pressure during the endoscopy, Use of sedatives, VAS of pain of the endoscopy, Endoscopy time, VAS of Operability in the endoscopy, Adverse events caused by using the shielding devise, Video of the diffusion of droplets in the endoscopy room, etc.

Countries

Japan

Contacts

Public ContactDaisuke Kikuchi

Toranomon Hospital Department of Gastroenterology

dkiku1230@gmail.com03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026